Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 4 Interventional

A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension

ClinicalTrials.gov ID: NCT05203510

Public ClinicalTrials.gov record NCT05203510. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 5:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Prospective, Multicenter, Single-Arm Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Patients With Pulmonary Arterial Hypertension: ARTISAN (Afterload Reduction To Improve Right Ventricular Structure And FuNction)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to assess the effect of early and rapid treprostinil therapy for mean pulmonary artery pressure (mPAP) reduction to improve right ventricular (RV) function and reverse RV remodeling in participants with pulmonary arterial hypertension (PAH).

Study identification

NCT ID
NCT05203510
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
United Therapeutics
Industry
Enrollment
52 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 20, 2022 (Actual)
Primary completion
Apr 30, 2026 (Estimated)
Completion
Apr 30, 2028 (Estimated)
Last update posted
Dec 9, 2025

2022 – 2028

United States locations

U.S. sites
28
U.S. states
19
U.S. cities
26
Facility City State ZIP Site status
Banner University Medical Center (University of Arizona) Phoenix Arizona 85006 —
HonorHealth John C. Lincoln Medical Center Phoenix Arizona 85020 —
University of California San Francisco - Fresno Fresno California 93701 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
University of California Davis Medical Center Sacramento California 95817 —
University of California San Francisco Pulmonary, Critical Care, Allergy and Sleep Medicine San Francisco California 94143 —
Hartford Hospital Hartford Connecticut 06106 —
USF Tampa Florida 33606 —
Georgia Clinical Research Austell Georgia 30106 —
Northwestern Memorial Hospital Chicago Illinois 60611 —
Indiana University Health North Hospital Indianapolis Indiana 46202 —
Community Health Network Indianapolis Indiana 46219 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Henry Ford Health System Detroit Michigan 48202 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
Morristown Medical Center Morristown New Jersey 07960 —
University of Rochester Medical Center Rochester New York 14623 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599 —
Duke University Medical Center Durham North Carolina 27710 —
University of Cincinnati Cincinnati Ohio 45267 —
The Ohio State University Wexner Medical Center Columbus Ohio 43210 —
Integris Baptist Medical Center Oklahoma City Oklahoma 73112 —
Oklahoma Heart Institute Tulsa Oklahoma 74104 —
Temple Hospital Philadelphia Pennsylvania 19140 —
Medical University of South Carolina Charleston South Carolina 29425 —
Prisma Health Greenville South Carolina 29605 —
UT Southwestern Medical Center Dallas Texas 75390 —
Carilion Clinic Roanoke Virginia 24014 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05203510, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2025 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05203510 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →